Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Fainting; POTS; inappropriate sinus tachycardia; This is a spontaneous report received from a Consumer or other non HCP. A 23-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Concomitant vaccines and prior vaccinations within 4 weeks were none. The following information was reported: SYNCOPE (disability), outcome "not recovered", described as "Fainting"; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (disability), outcome "not recovered", described as "POTS"; INAPPROPRIATE SINUS TACHYCARDIA (disability), outcome "not recovered". The clinical course was reported as follows: The patient experienced fainting, and was diagnosed with postural orthostatic tachycardia syndrome (POTS) and inappropriate sinus tachycardia after receiving vaccine. She had been healthy prior to this. The patient took medication to treat the events. Therapeutic measures were taken as a result of syncope, postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.